Raffael Nachbagauer

35PUBLICATIONS
137CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jun 15, 2026
mRNA-based influenza vaccine expands the B cell response breadth in humans.

|Oct 10, 2025
Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunization.

Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying

|Jul 02, 2025
Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase.

Amanda K Rudman Spergel, Ivan T Lee, Kindra Koslovsky

|Dec 23, 2024
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein.

Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying

|Dec 18, 2024
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus.

Masato Hatta, Yasuko Hatta, Angela Choi

|Jun 19, 2023
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.

Ivan T Lee, Raffael Nachbagauer, David Ensz

Pageof 6

Frequent Collaborators

21 joint publications

Florian Krammer

7 joint publications

Daniel Stadlbauer

7 joint publications

Adolfo García-Sastre

6 joint publications

Peter Palese